Physician profile
Scott Caldwell
NPI 1114435088
$2,098.20
in general payments reported to CMS, 2019-2025
14 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $545 · 2022: $525 · 2023: $575 · 2024: $280 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,342.24 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $156.42 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $124.89 | 2023-2024 | Lithovue, Ams 700 Cxr Rte Kit |
| Urovant Sciences INC | $75.30 | 2022 | |
| Endo Pharmaceuticals INC. | $56.60 | 2021-2023 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $56.05 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $54.96 | 2023 | |
| 180 Medical, INC. | $53.18 | 2022 | |
| Blue Earth Diagnostics | $46.89 | 2021-2022 | |
| Abbvie INC. | $45.77 | 2023-2025 | |
| Myovant Sciences INC. | $27.71 | 2022 | |
| Tolmar, INC. | $24.32 | 2023 | |
| Procept Biorobotics Corporation | $19.32 | 2025 | |
| Medtronic, INC. | $14.55 | 2023 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Caldwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.